A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of Tazarotene and Tazarotene Vehicle Lotion in the Treatment of Acne Vulgaris
Phase of Trial: Phase III
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Tazarotene
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- Sponsors Ortho Dermatologics; Valeant Pharmaceuticals International
- 11 Aug 2017 Status changed from not yet recruiting to recruiting.
- 27 Jul 2017 According to Valeant Pharmaceuticals International media release, Valeant Pharmaceuticals International renamed its dermatolgy unit as Ortho Dermatologics.
- 12 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jul 2017.